BETHLEM MYOPATHY
|
BETHLEM MYOPATHY (BM)
|
BETHLEM MYOPATHY, AUTOSOMAL RECESSIVE
|
C2 DEFICIENCY, TYPE II
|
DEAFNESS, AUTOSOMAL DOMINANT 9
|
EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE
|
EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT (DDEB)
|
EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE (RDEB)
|
EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE,
|
EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE (HS-DEB)
|
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PASINI TYPE (P-DEB)
|
EPIDERMOLYSIS BULLOSA PRURIGINOSA (EBP)
|
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5
|
GAPO SYNDROME
|
GLANZMANN THROMBASTHENIA
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4
|
HYALINE FIBROMATOSIS SYNDROME
|
LEUKOCYTE ADHESION DEFICIENCY
|
MACULAR DEGENERATION, AGE-RELATED, 14, REDUCED RISK OF
|
NAIL DISORDER, NON-SYNDROMIC CONGENITAL, 8 (NDNC8)
|
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN (TBDN)
|
ULLRICH CONGENITAL MUSCULAR DYSTROPHY (UCMD)
|
ULLRICH CONGENITAL MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE
|
VON WILLEBRAND DISEASE, TYPE 1, INCLUDED
|
VON WILLEBRAND DISEASE, TYPE 1, SUSCEPTIBILITY TO
|
VON WILLEBRAND DISEASE, TYPE 2A
|
VON WILLEBRAND DISEASE, TYPE 2B
|
VON WILLEBRAND DISEASE, TYPE 2CB
|
VON WILLEBRAND DISEASE, TYPE 2M
|
VON WILLEBRAND DISEASE, TYPE 3
|